Your browser doesn't support javascript.
loading
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple Myeloma.
Shi, Yijiang; Sun, Fumou; Cheng, Yan; Holmes, Brent; Dhakal, Binod; Gera, Joseph F; Janz, Siegfried; Lichtenstein, Alan.
Afiliación
  • Shi Y; Department of Hematology-Oncology, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California.
  • Sun F; Department of Research & Development, Greater Los Angeles VA Healthcare System, UCLA School of Medicine, Los Angeles, California.
  • Cheng Y; Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Holmes B; Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
  • Dhakal B; Department of Hematology-Oncology, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California.
  • Gera JF; Department of Research & Development, Greater Los Angeles VA Healthcare System, UCLA School of Medicine, Los Angeles, California.
  • Janz S; Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Lichtenstein A; Department of Hematology-Oncology, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California.
Mol Cancer Ther ; 21(4): 502-510, 2022 04 01.
Article en En | MEDLINE | ID: mdl-35086951

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Ribonucleoproteína Nuclear Heterogénea A1 / Ratones / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Ribonucleoproteína Nuclear Heterogénea A1 / Ratones / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos